Diversification in vaccine suppliers only way to secure millions of doses: Procurement minister
WASHINGTON - The White House tells The Associated Press that the U.S. will begin sharing its entire stock of COVID-19 vaccines from AstraZeneca once the vaccine clears federal safety reviews.
As many as 60-million doses are expected to be available for export in the coming months.
The move greatly expands on the Biden administration's action last month to share about four-million doses of the vaccine with Mexico and Canada.
The Oxford-AstraZeneca drug is widely in use around the world but not yet authorized by the U.S. Food and Drug Administration.
BNN Bloomberg Picks
Adele license fees to help fund US$335M of bonds
Saving for retirement is becoming out of reach for young Canadians
Report recommends pegging minimum wages to average incomes
A recession would be worse in Canada than U.S.: Economist
Affordable worker housing is latest tourist town business hurdle
Spotify's billion-dollar bet on podcasting has yet to pay off